Circumvent

Circumvent Pharmaceuticals is a biotechnology company focused on developing precision medicines for neurodegenerative diseases, with an initial emphasis on Batten Disease. The company aims to address the growing challenge of neurodegenerative conditions, which are projected to become a leading cause of death worldwide in the coming decades. Circumvent's mission is driven by the need for innovative treatments, particularly in light of the limited progress made in disease-modifying therapies due to a lack of understanding of the underlying mechanisms of these diseases.

The company has assembled…